The Savvy Diabetic Blog
395 FOLLOWERS
I'm Joanne Laufer Milo. I have Type 1 diabetes. The Savvy Diabetic is a blog about Type 1 diabetes. The goal is to share information about new technologies, exciting research, cool and helpful topics about living with T1D, tips on being prepared as a T1D plus stories about T1Ds and their pets!
The Savvy Diabetic Blog
2d ago
Location, location, location. Does cannula site affect AID performance? by Tim Street for Diabettech.com, 7 November 2024.
Rotate your injection or infusion sites. That’s a key message that anyone living with type 1 is delivered very early in their life with the condition. And for good reason. Nobody wants to have to live with scar tissue or lipohypertrophy affecting their insulin absorption.
But within the advice about location lies another reality, before we get to any tissue damage ..read more
The Savvy Diabetic Blog
1w ago
In this week’s issue of The Savvy Diabetic:
Omnipod 5 & the iPhone App
Abbott CGM Sensors OK in MRI
FDA Rejects Sotagliflozin for T1D
Chinese Stem Cell-Based Therapies
Semaglutide for Knee Osteoarthritis Pain
Beta Bionics Launches iLet with Abbott FreeStyle Libre 3 Plus
AI For Diabetes with Cardiomyopathy
Insulcloud Cleared by FDA for Insulin Pens
Dexcom CCO to Retire Following Sales Restructuring
Insulet rolls out iPhone app for Omnipod 5 insulin pump in US by GlobalData.com, 31 October 2024. The app allows users to control the Omnipod 5 from the phone instead of carrying a ..read more
The Savvy Diabetic Blog
2w ago
In this week’s issue of The Savvy Diabetic:
New Insulin to Prevent Sudden BG Drops
Luna Diabetes Clinical Trial for AID Closed-Loop for MDI
Levicure’s Triple-Combo Oral Therapy to Restore Insulin Production
GLP-1, SGLT2 Drug Scripts on the Rise for T1Ds
Diabetes Technology Society Showcased Innovations in Diabetes Management
Semaglutide Linked to Reduced Risk for Alzheimer’s in Diabetics
Scientists Track Age You’re Most Likely to be Hospitalized
Medicare Advantage Insurers Under Fire by US Senate
MultiPlan Accused of Conspiring with Health Insurers to Underpay Doctors
New t ..read more
The Savvy Diabetic Blog
3w ago
In this week’s issue of The Savvy Diabetic:
A Cure for T1D by Disguising Stem Cells?
Stem Cell-Derived Islets Restore Insulin Production in T1D
GLP1-RAs and T1D with Open Source AIDs
FDA Removes Zepbound & Mounjaro from Shortage List
Teen Receives Teplizumab (Tzield) to Delay Onset of T1D
Scientist hopes to cure Type 1 diabetes by disguising stem cells by Brian Brennan for HealthSciences.arizona.edu, 9 October 2024 ..read more
The Savvy Diabetic Blog
1M ago
It was a quiet week for diabetes news, in this issue of The Savvy Diabetic:
Somatostatin May Protect Against Sudden BG Drops
Sernova’s Cell Pouch Contains Vascularized, Functioning Islets > 5 years
A Spoonful of Laughter for dStimatize.org (diaTribe)
Potential strategy against blood glucose drops in type 1 diabetes by University of Gothenburg for ScienceDaily.com, 30 September 2024 ..read more
The Savvy Diabetic Blog
1M ago
In this week’s issue of The Savvy Diabetic:
Stem cells Reverse T1D
Microtech Linx CGM (a fail?)
FDA Releases Clinical Hold on Biomea Fusion’s BMF-219
StartUp Health Podcast: WiNK Therapeutics & Sensulin
Heat/dust Increase Diabetes Hospitalizations
Gina Pillina, T1D and Illustrator Extraordinaire!
Stem cells reverse woman’s diabetes — a world first by Smriti Mallapaty for Nature.com, 26 September 2024.
A 25-year-old woman with type 1 diabetes started producing her own insulin less than three months after receiving a transplant of reprogrammed stem cells ..read more
The Savvy Diabetic Blog
1M ago
In this week’s issue of The Savvy Diabetic:
Geofencing/Dexcom G7 Update! with Jake Leach
Senseonics Gets FDA Clearance for 1-year CGM
Abbott Ramps Up Libre 3 Production
AI Model to Predict Diabetic Retinopathy
GC Therapeutics “Supercell” Medicines
SymbioCellTech’s Stem Cell-Enabled Therapy
How to Appeal Insurance Denials
Type 1 Diabetes & Brain Development
FTC & PMBs Sue Each Other
Using ChatGPT to Diagnose
Geofencing/Dexcom G7 Update ..read more
The Savvy Diabetic Blog
2M ago
Continuous Glucose Monitoring (CGM) Sensor Recall: Abbott Diabetes Care Inc Issues Recall for Certain FreeStyle Libre 3 Sensors due to Risk for Inaccurate High Glucose Readings posted by FDA.gov/medical-devices, 5 September 2024.
This recall involves removing certain devices from where they are used or sold, and does not apply to the FreeStyle Libre 3 reader or app. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it. This recall involves removing certain devices from where they are used ..read more
The Savvy Diabetic Blog
2M ago
Abbott debuts Lingo over-the-counter CGM in the US by Elise Reuter for MedTechDive.com, 6 September 2024. Priced at $49 for one 14-day sensor, or $89 per month, Abbott’s offering is competitive with Dexcom’s Stelo sensor.
Abbott’s Lingo is intended to show people how diet and exercise affect blood glucose levels. The sensor hardware is similar to Abbott’s prescription CGMs, but the app presents different information. The app includes a graph of glucose readings, a count of glucose spikes, and food and activity logging ..read more
The Savvy Diabetic Blog
2M ago
Dexcom prices first over-the-counter glucose monitor by Elise Reuter for MedTechDive.com, 26 August 2024.
Diabetes technology company Dexcom began selling its first over-the-counter continuous glucose monitor (CGM) on Monday. The device, called Stelo, will cost $89 for a monthly subscription or $99 for a one-time order of two sensors. BTIG analyst Marie Thibault said the price was “in line with our prior $100 per month assumption.” Dexcom’s device is intended for people with Type 2 diabetes who don’t take insulin, although it can be used by people without diabetes ..read more